Demo
ALPMY OTCM· Astellas Pharma Inc.
FundamentalsNews digest Peer analysis
Login
ALPMY OTCM· Astellas Pharma Inc.
Earnings report Q

Source documents

Form   filed on Invalid Date
pages scanned

Reference data

Company financials Q revenue 421.9B
Analyst estimates Q EPS missed by NaN%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.